• Fatima Rodriguez and Kenneth W Mahaffey.
• Stanford University School of Medicine, Department of Medicine, Division of Cardiovascular Medicine, Stanford, California.
• J. Am. Coll. Cardiol. 2016 Jul 19; 68 (3): 313-321.

AbstractNon-ST-segment elevation acute coronary syndromes (NSTE-ACS) are the leading cause of morbidity and mortality from cardiovascular disease worldwide. The American Heart Association/American College of Cardiology and the European Society of Cardiology periodically release practice guidelines to guide clinicians in the management of NSTE-ACS, most recently in in 2014 and 2015, respectively. The present review compares and contrasts the 2 guidelines, with a focus on the strength of recommendation and level of evidence in the approach to initial presentation and diagnosis of NSTE-ACS, risk assessment, treatments, and systems of care. Important differences include the use of a rapid rule-out protocol with high-sensitivity troponin assays, a preference for prasugrel/ticagrelor and fondaparinux for anticoagulation therapy, and a preference for radial arterial access in the European Society of Cardiology guidelines compared with the American Heart Association/American College of Cardiology guidelines. We also highlight the similarities and differences in the guidelines for special patient populations and suggest areas of further study.Copyright © 2016 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

17 keywords...

hide…